Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Evaluating fluvoxamine for the outpatient treatment of COVID‐19: A systematic review and meta‐analysis
Jiawen Deng, Myron Moskalyk, Qi Zuo, et al.
Reviews in Medical Virology (2023) Vol. 34, Iss. 1
Open Access | Times Cited: 9

Showing 9 citing articles:

Self‐ or Acridinium‐Catalyzed Electrophotosynthesis of Thiocyanato Heterocycles from Activated Alkenes
Kaixing Gong, Yingchun Ma, Ping Yu, et al.
Advanced Synthesis & Catalysis (2024) Vol. 366, Iss. 10, pp. 2352-2362
Closed Access | Times Cited: 9
Electrophotocatalysis Versus Indirect Electrolysis: Electrochemical Selenocyclization of 3‐Aza‐1,5‐dienes Facilitated by Energy Transfer, Direct Photolysis or N‐Hydroxyphthalimide
Dongyin Wang, Li Zeng, Jifu Shi, et al.
Chemistry - A European Journal (2024) Vol. 30, Iss. 36
Closed Access | Times Cited: 6
Eleven new metabolites of fluvoxamine detected in the solid tissues and body fluids obtained from a deceased overdosed with fluvoxamine in vivo, and the metabolites in the human liver microsomes in vitro using LC-HR–MS/MS
Kayoko Minakata, Hideki Nozawa, Itaru Yamagishi, et al.
Forensic Toxicology (2025)
Closed Access
COVID-19-associated mortality in individuals with serious mental disorders in Sweden during the first two years of the pandemic– a population-based register study
Anna Gibbs, Martin Maripuu, Louise Öhlund, et al.
BMC Psychiatry (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Systems medicine framework for repurposable drug combinations for COVID-19 comorbidities
S. Saranya, L. Thamanna, P. Chellapandi
Medicine in Omics (2024) Vol. 11, pp. 100038-100038
Open Access | Times Cited: 1
Fluvoxamine and long COVID: Post‐acute recovery
Angela M. Reiersen, Charles F. Zorumski, Eric J. Lenze
Reviews in Medical Virology (2024) Vol. 34, Iss. 4
Closed Access | Times Cited: 1
Die Bedeutung von Antidepressiva bei COVID-19 und Long-COVID – Ein Scoping-Review Update
Udo Bonnet, Georg Juckel
Fortschritte der Neurologie · Psychiatrie (2024)
Closed Access | Times Cited: 1
Drug–Drug Interactions of Selective Serotonin Reuptake Inhibitors: A Pharmacovigilance Study on Real-World Evidence from the EudraVigilance Database
Carmen Maximiliana Dobrea, Adina Frum, Anca Butucă, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 10, pp. 1278-1278
Open Access | Times Cited: 1
DABCO‐Mediated Photoelectrochemical Three‐Component Sulfonocyclization of 3‐Aza‐1,5‐dienes
Lu-Cai Ding, Gui-Hong Yang, Li Luo, et al.
Chinese Journal of Chemistry (2024)
Closed Access | Times Cited: 1
Page 1

Scroll to top